CLINICAL_TRIALS
trial_result
· 2023-10-10
Clinical Trial Update: An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer [Phase 2]
Summary
This update reports efficacy and safety data from a Phase 2 trial of Erdafitinib in participants with urothelial cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Urothelial Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-10-10